Received: 13 April 2018
Accepted: 13 July 2018
First Online: 21 July 2018
Ethics approval and consent to participate
: The GP-OSMOTIC trial, incorporating this study, was approved by The University of Melbourne Human Research Ethics Committee (ID 1647151.3). Written informed consent to participate was obtained from all participants. Our ethics committee approved our method of consent.
: Not applicable.
: JF has received unrestricted educational grants for research support from Roche, Sanofi and Medtronic.DO is on the advisory boards to Abbott Diabetes Care, and Novo-Nordisk. DO and JAMN have had various financial relationships with pharmaceutical industries outside the submitted work including consultancies, grants, lectures, educational activities and travel. AJ is on an advisory board to Abbott Diabetes care and has had research grants and educational activities supported by various pharmaceutical industries outside the submitted work. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.